- One target, different effects: a comparison of distinct therapeutic antibodies against the same targets
-
Shim H
- KMID: 1123366
- Exp Mol Med.
- 2011 Oct;43(10):539-549.
- doi: 10.3858/emm.2011.43.10.063
To date, more than 30 antibodies have been approved worldwide for therapeutic use. While the monoclonal antibody market is rapidly growing, the clinical use of therapeutic antibodies is mostly limited... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of c-erbB-2 and c-met Proteins in Gastric Adenoma and Adenocarcinoma
-
Lee SW, Kang SB, Kim YS, Nam SW, Lee DS, Lee HK, Han SW
- KMID: 782837
- Korean J Gastroenterol.
- 2007 Mar;49(3):152-157.
BACKGROUND/AIMS: The aim of this study was to investigate the immunohistochemical overexpression of c-erbB-2 and c-met proteins according to the histopathological parameters such as grade of dysplasia, histological type, depth... -
- CITED
-
- Close
- SHARE
-
- Close
- Trastuzumab-Conjugated Liposome-Coated Fluorescent Magnetic Nanoparticles to Target Breast Cancer
-
Jang M, Yoon YI, Kwon YS, Yoon TJ, Lee HJ, Hwang SI, Yun BL, Kim SM
- KMID: 1731043
- Korean J Radiol.
- 2014 Aug;15(4):411-422.
- doi: 10.3348/kjr.2014.15.4.411
OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to... -
- CITED
-
- Close
- SHARE
-
- Close
